3230 Results

People

  1. Schoder
    Schoder
  2. Larson
    Larson
  3. Pandit-Taskar
    Pandit-Taskar
  4. Humm
    Humm
  5. Vargas Alvarez
    Vargas Alvarez
  6. Bodei
    Bodei
  7. Finn
    Finn
  8. Weber
    Weber
  9. Zanzonico
    Zanzonico
  10. Strauss
    Strauss

Groups

  1. Molecular Imaging and Therapy Service (3230)
  2. Radiology, Department of (3052)
  3. GSK Faculty (1475)
  4. Sloan Kettering Institute Faculty (1241)
  5. Molecular Pharmacology and Chemistry Program Faculty (1226)
  6. Department of Medicine (983)
  7. Sloan Kettering Institute Postdocs (864)
  8. Body Imaging Service (649)
  9. Solid Tumor Oncology Division (647)
  10. Medical Physics (628)
  1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (1812)
  2. Meeting Abstract (932)
  3. Book Section (169)
  4. Review (156)
  5. Editorial (44)
  6. Conference Paper (40)
  7. Guidelines (31)
  8. Miscellaneous (18)
  9. Correspondence (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Molecular Imaging and Therapy Service (3230)
  2. Radiology, Department of (3052)
  3. GSK Faculty (1475)
  4. Sloan Kettering Institute Faculty (1241)
  5. Molecular Pharmacology and Chemistry Program Faculty (1226)
  6. Department of Medicine (983)

More Groups

People
  1. Steven Larson (957)
  2. Heiko Schoder (543)
  3. Neeta Pandit-Taskar (342)
  4. John Humm (281)
  5. Hebert Vargas Alvarez (267)
  6. Lisa Bodei (205)

More People

Years
  1. 2025 (40)
  2. 2024 (129)
  3. 2023 (176)
  4. 2022 (175)
  5. 2021 (197)
  6. 2020 (195)

More Years

Publications
  1. Journal of Nuclear Medicine (569)
  2. Journal of Clinical Oncology (248)
  3. European Journal of Nuclear Medicine and Molecular Imaging (130)
  4. Blood (97)
  5. International Journal of Radiation Oncology, Biology, Physics (73)
  6. Clinical Nuclear Medicine (72)

More Publications

Publishers
  1. Society of Nuclear Medicine (569)
  2. Springer (430)
  3. Elsevier Inc. (303)
  4. American Society of Clinical Oncology (259)
  5. Lippincott Williams & Wilkins (154)
  6. American Association for Cancer Research (150)

More Publishers

Results (3230)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas
    Journal Article

    Moskowitz, A. J.; Ghione, P.; Jacobsen, E.; Ruan, J.; Schatz, J. H.; Noor, S.; Myskowski, P.; Vardhana, S.; Ganesan, N.; Hancock, H.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Dosimetry in clinical radiopharmaceutical therapy of cancer: Practicality versus perfection in current practice
    Review

    Pandit-Taskar, N.; Iravani, A.; Lee, D.; Jacene, H.; Pryma, D.; Hope, T.; Saboury, B.; Capala, J.; Wahl, R. L.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Tumor response to radiopharmaceutical therapies: The knowns and the unknowns
    Review

    Sgouros, G.; Dewaraja, Y. K.; Escorcia, F.; Graves, S. A.; Hope, T. A.; Iravani, A.; Pandit-Taskar, N.; Saboury, B.; James, S. S.; Zanzonico, P. B.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Low incidence rates of mucositis, febrile neutropenia or sepsis in the prospective, randomized phase 3 SIERRA trial for patients with relapsed or refractory acute myeloid leukemia with targeted delivery of anti-CD45 iodine ((131)I) apamistamab [Iomab-B]
    Meeting Abstract

    Natwa, M.; Passalaqua, S.; Chen, M. K.; Wagner, R.; Yap, W.; Griffeth, L.; Wiseman, G.; Mhlanga, J.; Wahl, R.; Avril, N.; more...
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Relationship of marrow radiation dose and timing of engraftment for targeted radioimmunotherapy with anti-CD45 iodine ((131)I) apamistamab [Iomab-B] in patients with active relapsed or refractory acute myeloid leukemia
    Meeting Abstract

    Passalaqua, S.; Natwa, M.; Chen, M. K.; Wagner, R.; Yap, W.; Griffeth, L.; Wiseman, G.; Mhlanga, J.; Wahl, R.; Avril, N.; more...
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Blood based genomic assessment of the clinical efficacy and toxicity of peptide receptor radionuclide therapy (PRRT)
    Meeting Abstract

    Bodei, L.; Raj, N.; Do, R. K. G.; Krebs, S.; Reidy, D.; Kidd, M.; Drozdov, I.; Modlin, I.; Schoder, H.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • (177)Lu-Dotatate plus long-acting octreotide versus high-dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): Final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial
    Journal Article

    Strosberg, J. R.; Caplin, M. E.; Kunz, P. L.; Ruszniewski, P. B.; Bodei, L.; Hendifar, A.; Mittra, E.; Wolin, E. M.; Yao, J. C.; Pavel, M. E.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Patient size-dependent dosimetry methodology applied to (18)F-FDG using new ICRP mesh phantoms
    Journal Article

    Carter, L. M.; Choi, C.; Krebs, S.; Beattie, B. J.; Kim, C. H.; Schoder, H.; Bolch, W. E.; Kesner, A. L.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Temporal relationship between (18)F-sodium fluoride uptake in the abdominal aorta and evolution of CT-verified vascular calcification
    Journal Article

    Nakahara, T.; Narula, J.; Fox, J. J.; Jinzaki, M.; Strauss, H. W.
    Journal of Nuclear Cardiology (2021)

    Fulltext@MSK | Save
  • Synthesis and morphological studies of Tc-99m-labeled lupulone-conjugated Fe(3)O(4)@TiO(2) nanocomposite, and in vitro cytotoxicity activity on prostate cancer cell lines
    Journal Article

    Tutun, E.; Tekin, V.; Yasakcı, V.; Aras, Ö; Ünak, P.
    Applied Organometallic Chemistry (2021)

    Fulltext@MSK | Save